ClinicaliQ Trial Snapshot
- Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR — Active Not Recruiting • Infectious Disease • NCT06824129.
- A rapid urine test accurately identifies bacteria causing urinary tract infections and detects antibiotic resistance.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Performance evaluation of QIAstat-Dx cUTI Plus AMR Panel using the QIAstat-Dx® Analyzer to demonstrate that the QIAstat-Dx cUTI Plus AMR Panel achieves its intended performance during normal conditions of use by the intended user in the intended environment Conditions: Complicated Urinary Tract Infection Lead Sponsor: QIAGEN Gaithersburg, Inc Planned Enrollment: 1500 participants